THOMPSON DAVIS & CO., INC. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 115 filers reported holding MIRATI THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.7%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$41,000
-33.9%
875
-30.0%
0.09%
-39.9%
Q2 2018$62,000
+63.2%
1,2500.0%0.15%
+48.0%
Q1 2018$38,000
+40.7%
1,250
-16.7%
0.10%
+56.2%
Q4 2017$27,000
+350.0%
1,500
+200.0%
0.06%
+481.8%
Q3 2017$6,0005000.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders